|
Volumn 21, Issue 3, 2016, Pages 1-3
|
Actikerall™ (5-Fluorouracil 0.5% and Salicylic Acid 10%) Topical Solution for Patient-directed Treatment of Actinic Keratoses
a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
DRUG COMBINATION;
FLUOROURACIL;
SALICYLIC ACID;
SOLUTION AND SOLUBILITY;
CLINICAL TRIAL (TOPIC);
DRUG COMBINATION;
HUMAN;
KERATOSIS, ACTINIC;
PATHOLOGY;
SOLUTION AND SOLUBILITY;
TOPICAL DRUG ADMINISTRATION;
ADMINISTRATION, TOPICAL;
CLINICAL TRIALS AS TOPIC;
DRUG COMBINATIONS;
FLUOROURACIL;
HUMANS;
KERATOSIS, ACTINIC;
SALICYLIC ACID;
SOLUTIONS;
|
EID: 85016923629
PISSN: 12015989
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (5)
|
References (0)
|